Compare VanEck Junior Gold Miners (GDXJ) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Junior Gold Miners vs Pfizer Inc — how do they compare? VanEck Junior Gold Miners trades at $119.8, while Pfizer Inc trades at $26.31 (market cap $151.73B). The key difference: Pfizer Inc pays a 6.46% dividend while VanEck Junior Gold Miners pays none. Which is the better fit depends on your goals.
| GDXJ | PFE | |
|---|---|---|
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $156.19 | $28.56 |
52-Week Low | $71.22 | $23.60 |
Market Cap | — | $151.73B |
Volume | — | 29,869,932 |
Enterprise Value | — | $203.22B |
Dividend Yield | — | 6.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GDXJ trades at $120.71, up 1.62% today, with a bullish technical trend from moving averages but overbought signals from RSI levels. The ETF faces mixed sentiment, with recent news highlighting institutional selling by Amundi and underperformance versus peers in 2026. Support lies near $116, with resistance at $121.
The outlook is cautious due to high RSI readings and bearish oscillators, suggesting potential near-term pullbacks. Risks include Federal Reserve policy impacts on gold prices and competitive pressures from larger miner ETFs. Institutional activity shows reduced positions, indicating tempered confidence.
Pfizer (PFE) trades at $27.05, up 1.16% with a bullish technical signal and consistent earnings beats in recent quarters. Revenue remains stable around $62-63 billion, though net income is projected to decline in 2026. The stock shows strong profitability margins and a solid balance sheet, but faces headwinds from patent expirations and competitive pressures.
The outlook is mixed: valuation multiples appear reasonable, and analyst consensus leans hold with a $27.86 target. Key risks include execution on pipeline catalysts and margin compression. Upside depends on successful drug launches and cost management amid a challenging revenue environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
